海外の治験の状況「1」での検索結果
1993件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- Effect of Otelixizumab in New-Onset Type 1 Diabetes Mellitus (NOT1DM)
- NOT1DM is an autoimmune disease. This means that the immune system, the part of the body which usually helps to fight infections, mistakenly attacks cells that produce insulin in the body. Insulin is necessary for the uptake of sugar from the blood MedDRA version: 18.0 Level: LLT Classification code 10003814 Term: Autoimmune disease, not elsewhere classified System Organ Class: 100000004870 ;Therapeutic area: Body processes [G] - Immune system processes [G12]
- Belgium
- 2013-11-18
Authorised
- Treatment of LADA(latent autoimmune diabetes in the adult).
- Latent Autoimmune diabetes of the adult (LADA) is a form of diabetes where the onset of the diabetes starts after 30 years of age, there is presence of beta-cell directed antibodies (mostly anti-GAD) and no clinical need for insulin during the first 3 months after the diagnosis of diabetes. MedDRA version: 17.1 Level: PT Classification code 10066389 Term: Latent autoimmune diabetes in adults System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Finland, Sweden
- 2009-08-05
Authorised
- A Study to Investigate the Dose Response of Dance 501 in Subjects with Type 1 Diabetes Mellitus (T1DM)
- Type 1 Diabetes Mellitus br>MedDRA version: 20.0 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Germany
- 2018-09-25
Authorised
- Evaluation of the relative severity of pulmonary neutrophilic inflammation and therapeutic modification with IV Prolastin by means of 18 FDG PET/CT scanning in subjects with alpha1-antitrypsin deficiency. - ECLIPSE AATD
- The medical condition is emphysema and will be investigated in subjects with alpha 1-antitrypsin deficiency. MedDRA version: 9.1 Level: LLT Classification code 10001811 Term: Alpha-1 proteinase inhibitor deficiency MedDRA version: 9.1 Level: LLT Classification code 10014563 Term: Emphysema pulmonary MedDRA version: 9.1 Level: LLT Classification code 10010952 Term: COPD MedDRA version: 9.1 Level: LLT Classification code 10006458 Term: Bronchitis chronic
- United Kingdom
- 2008-04-04
Authorised
- A clinical trial looking at the safety and effectiveness of a new drug for inhalation, looking to treat Alpha-1 Antitrypsin Deficient Patients with Emphysema.
- Alpha-1 Antitrypsin deficiency in patients with emphysema. MedDRA version: 17.0 Level: PT Classification code 10001806 Term: Alpha-1 anti-trypsin deficiency System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
- Denmark, Germany, Ireland, Netherlands, Sweden, United Kingdom
- 2009-08-07
Authorised
- A DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED, SEQUENTIAL GROUP, MULTIPLE DOSE STUDY OF THE EFFICACY OF THE CRF1-RECEPTOR ANTAGONIST R317573 ON CCK-4 INDUCED ANXIETY IN HEALTHY MALE SUBJECTS. - N/A
- Anxiety and depression
- Netherlands
- 2006-03-29
Authorised
- Phase I study of concurrent with involved-field thoracic radiotherapy for inoperable non-squamous cell lung cancer, followed by both concurrent and maintenance Bevacizumab - Phase I study of Bevacizumab and thoracic radiotherapy for non-squamous cell lung cancer
- Patients with locally advanced (stages II-IIIB) non-small cell lung cancer who are eligible for high-dose radiotherapy following the completion of induction systemic chemotherapy.
- Netherlands
- 2006-07-28
Authorised
- Can Angiotensin II type 1 Receptor Inhibitor Be Used to Lower the Amount of Lipase and Amylase Level after Endoscopic Retrograde Cholangio-Pancreatography? - AT1-antagonist and post-ERCP-complications
- The clinical diagnosis of acute pancreatitis is set by a combination of symptoms (abdominal pain) and increased blood levels of pancreatic enzymes (i.e. amylase and lipase). The most common complication of Endoscopic Retrograde Cholangio-Pancreatography (ERCP) is acute pancreatitis (7%, Freeman et al 1996). Increased blood levels of amylase and lipase is seen in 25-40% of cases after ERCP (Tsujino et al 2005).
- Sweden
- 2006-01-03
Authorised
- Protocol F1D-MC-HGKR. Olanzapine Plus Carbamazepine Versus Carbamazepine Alone in the Treatment of Manic or Mixed Episodes Associated with Bipolar I Disorder
- Manic or Mixed Episodes Associated with Bipolar I Disorder
- Hungary
- 2004-08-03
Authorised
- DOES BENFOTIAMINE SUPPLEMENTATION REDUCE SERUM LEVELS OF ADVANCED GLYCATION END PRODUCTS AND BIOCHEMICAL MARKERS OF VASCULAR DYSFUNCTION IN TYPE 1 DIABETES?
- Type 1 diabetes
- Norway
- 2004-06-25
